Splintless Virtual Surgical Plan with Mandible-first Technique: 3D Accuracy Analysis
MandiFirst
1 other identifier
observational
28
1 country
1
Brief Summary
Accuracy assessment through three-dimensional superposition of the post-operative volumetric CT and the digital therapeutic project files.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 24, 2024
CompletedFirst Submitted
Initial submission to the registry
May 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedFirst Posted
Study publicly available on registry
April 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 2, 2025
June 1, 2024
5 months
May 18, 2024
March 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy evaluation
3D superposition of post-operative volumetric CT and the digital therapeutic project files. The variables and parameters analysis will be performed after the data distribution analysis, using the D'Agostino Pearson omnibus normality test: normal distribution data will be expressed as mean and standard deviation; non-normal distribution data will be expressed as median and interquartile range. The quantitative and qualitative variables will be expressed in terms of absolute frequencies and percentage value. Image superposition accuracy will be defined by measuring distances between the different anatomical reference points, considering excellent accuracy for distances less than 2 mm. Correlation and multivariate analysis models will be developed to define the secondary outcomes.
1 month post-op
Interventions
Maxillary LeFort I osteotomy and mandible osteotomy (BSSO) without intermediate splint.
Eligibility Criteria
Patients with diagnosis of dentoskeletal disorders
You may qualify if:
- Men and women
- Age over 18 and under 60
- Diagnosis of dento-skeletal dysmorphosis involving the middle third and lower part of the face
- Patients with consent to surgery
- Patients in good general health according to the evaluation of the PI and on the basis of the anamnesis and clinical examination
You may not qualify if:
- History of previous maxillomandibular fracture
- Treatment with anticoagulant drugs
- Treatment with intravenous bisphosphonates
- Treatment with anticonvulsants
- Patient's inability to maintain home hygiene standards in accordance with the study requirements
- History of drug and/or alcohol abuse
- Chronic corticosteroid therapy
- Radiotherapy, chemotherapy and/or immunosuppressive treatment or radiotherapy in the last 5 years
- Psychosis
- Pregnant or breastfeeding
- Poor compliance
- Endocrinological disorders in poor pharmacological control
- Other uncontrolled systemic conditions that preclude performing surgical procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Milan, 20157, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2024
First Posted
April 2, 2025
Study Start
April 24, 2024
Primary Completion
September 30, 2024
Study Completion
December 31, 2025
Last Updated
April 2, 2025
Record last verified: 2024-06